Merck : Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection

Media coverage

• Title	Merck : Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection
  Media name/outlet	4 Traders
  Country	United States
  Date	11/13/16
  Persons	Eric J Lawitz

• Title	Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates...
  Media name/outlet	Freshnews.com
  Country	United States
  Date	11/13/16
  Persons	Eric J Lawitz

• Title	Merck & Co Inc: Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection (Businesswire)
  Media name/outlet	Avanza Bank AB
  Country	Sweden
  Date	11/13/16
  Persons	Eric J Lawitz

• Title	Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained ...
  Media name/outlet	EIN News
  Country	United States
  Date	11/13/16
  Persons	Eric J Lawitz